These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37919900)

  • 1. Complete remission of tumors in mice with neoantigen-painted exosomes and anti-PD-1 therapy.
    Zhang Y; Zuo B; Yu Z; Zhao K; Zhang Y; He K; Seow Y; Yin H
    Mol Ther; 2023 Dec; 31(12):3579-3593. PubMed ID: 37919900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized neoantigen cancer vaccines: current progression, challenges and a bright future.
    Wu DW; Jia SP; Xing SJ; Ma HL; Wang X; Tang QY; Li ZW; Wu Q; Bai M; Zhang XY; Fu XF; Jia MM; Tang Y; Chen L; Li N
    Clin Exp Med; 2024 Sep; 24(1):229. PubMed ID: 39325256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.
    Baljon JJ; Kwiatkowski AJ; Pagendarm HM; Stone PT; Kumar A; Bharti V; Schulman JA; Becker KW; Roth EW; Christov PP; Joyce S; Wilson JT
    ACS Nano; 2024 Mar; 18(9):6845-6862. PubMed ID: 38386282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors.
    Haoyue W; Kexiang S; Shan TW; Jiamin G; Luyun Y; Junkai W; Wanli D
    Phytomedicine; 2024 Nov; 136():156224. PubMed ID: 39642461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.
    De Mattos-Arruda L; Vazquez M; Finotello F; Lepore R; Porta E; Hundal J; Amengual-Rigo P; Ng CKY; Valencia A; Carrillo J; Chan TA; Guallar V; McGranahan N; Blanco J; Griffith M
    Ann Oncol; 2020 Aug; 31(8):978-990. PubMed ID: 32610166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma.
    Hornsteiner F; Vierthaler J; Strandt H; Resag A; Fu Z; Ausserhofer M; Tripp CH; Dieckmann S; Kanduth M; Farrand K; Bregar S; Nemati N; Hermann-Kleiter N; Seretis A; Morla S; Mullins D; Finotello F; Trajanoski Z; Wollmann G; Ronchese F; Schmitz M; Hermans IF; Stoitzner P
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.
    Gebert J; Gelincik O; Oezcan-Wahlbrink M; Marshall JD; Hernandez-Sanchez A; Urban K; Long M; Cortes E; Tosti E; Katzenmaier EM; Song Y; Elsaadi A; Deng N; Vilar E; Fuchs V; Nelius N; Yuan YP; Ahadova A; Sei S; Shoemaker RH; Umar A; Wei L; Liu S; Bork P; Edelmann W; von Knebel Doeberitz M; Lipkin SM; Kloor M
    Gastroenterology; 2021 Oct; 161(4):1288-1302.e13. PubMed ID: 34224739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection.
    Xia H; Hoang MH; Schmidt E; Kiwala S; McMichael J; Skidmore ZL; Fisk B; Song JJ; Hundal J; Mooney T; Walker JR; Goedegebuure SP; Miller CA; Gillanders WE; Griffith OL; Griffith M
    Genome Med; 2024 Nov; 16(1):132. PubMed ID: 39538339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes derived from minor salivary gland mesenchymal stem cells: a promising novel exosome exhibiting pro-angiogenic and wound healing effects similar to those of adipose-derived stem cell exosomes.
    Xiang H; Ding P; Qian J; Lu E; Sun Y; Lee S; Zhao Z; Sun Z; Zhao Z
    Stem Cell Res Ther; 2024 Dec; 15(1):462. PubMed ID: 39627883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant ClearColi™-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma.
    Sharif E; Nezafat N; Mohit E
    Int Immunopharmacol; 2024 Dec; 143(Pt 2):113283. PubMed ID: 39418728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model.
    Mathlouthi S; Kuryk L; Prygiel M; Lupo MG; Zasada AA; Pesce C; Ferri N; Rinner B; Salmaso S; Garofalo M
    J Control Release; 2024 Dec; 376():777-793. PubMed ID: 39481685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized membrane protein vaccine based on a lipid nanoparticle delivery system prevents postoperative recurrence in colorectal cancer models.
    Shi G; Xu Y; Qiu H; Cao F; Xiao ZX; Zhang C; Zha GF
    Acta Biomater; 2024 Dec; ():. PubMed ID: 39637957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential predictive value of resident memory CD8
    Paolini L; Tran T; Corgnac S; Villemin JP; Wislez M; Arrondeau J; Johannes L; Ulmer J; Vieillard LV; Pineau J; Gey A; Quiniou V; Barennes P; Pham HP; Gruel N; Hasan M; Libri V; Mella S; De Percin S; Boudou-Rouquette P; Caidi A; Cremer I; Blons H; Leroy K; Laurent-Puig P; De Saint Basile H; Gibault L; Ravel P; Mami-Chouaib F; Goldwasser F; Fabre E; Damotte D; Tartour E
    J Immunother Cancer; 2024 Dec; 12(12):. PubMed ID: 39631852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers.
    McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT
    Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for maintenance of medically-induced remission in Crohn's disease.
    Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
    Zhang X; Goedegebuure SP; Chen MY; Mishra R; Zhang F; Yu YY; Singhal K; Li L; Gao F; Myers NB; Vickery T; Hundal J; McLellan MD; Sturmoski MA; Kim SW; Chen I; Davidson JT; Sankpal NV; Myles S; Suresh R; Ma CX; Foluso A; Wang-Gillam A; Davies S; Hagemann IS; Mardis ER; Griffith O; Griffith M; Miller CA; Hansen TH; Fleming TP; Schreiber RD; Gillanders WE
    Genome Med; 2024 Nov; 16(1):131. PubMed ID: 39538331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuing education meetings and workshops: effects on professional practice and healthcare outcomes.
    Forsetlund L; O'Brien MA; Forsén L; Reinar LM; Okwen MP; Horsley T; Rose CJ
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD003030. PubMed ID: 34523128
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.